#EyeInfectionTreatment

[intel-analytics360]

Bacterial Conjunctivitis Drugs Market Forecast 2024 to 2032

Bacterial conjunctivitis is one of the most commonly encountered eye problems in medicine. Most cases are acute, self-limited, and not a major cause of morbidity. However, because of its high prevalence, it has a large societal impact in terms of missed days of school or work. Antibiotics can hasten the resolution of symptoms and microbial eradication and are therefore typically used to allow patients to return to their daily activities faster and to decrease the spread of disease.

The Bacterial Conjunctivitis Drugs Market was valued at USD 506.31 Million in 2022 and is expected to register CAGR of 3.49% by 2032.

Key factors such as rising prevalence of bacterial conjunctivitis across the globe, increasing aging population, rising investments in developing drug-resistant strains, and rising awareness about eye health and bacterial conjunctivitis are expected to drive global market growth during the forecast period.

Get a Free Sample Copy